Fact CheckerSign in

NCT06011629CompletedPhase 4

Aquacel Hypersensitivity Dressing in TJAs

Prospective Evaluation of Type IV Hypersensitivity Reactions After Aquacel Dressing Application in Partial and Total Joint Arthroplasty Patients

Source: ClinicalTrials.gov · Last updated 4 Aug 2026

Brief summary (registry, in English)

The aim of this multi-surgeon, single institution study is to prospectively evaluate the incidence of allergic contact dermatitis (ACD) following application of AQUACEL Ag, a silver-containing hydrofiber dressing, in total hip and knee arthroplasty patients. Arthroplasty-naïve patients will be compared to prior total joint arthroplasty patients who received a Aquacel dressing postoperatively.

Status (registry)
Completed
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
457 (actual)
First submitted
21 Aug 2023
Start date
18 Jun 2023
Primary completion date
1 Nov 2024
Lead sponsor
Rush University Medical Center
NCT number
NCT06011629

What you commit to

  • Study type: Interventional · Phase 4
  • Participants enrolled: 457
  • From 18 Jun 2023 to the primary completion date, 1 Nov 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Revision surgery
  • Prior history of allergic contact dermatitis
  • Prior history of non-TJA or UKA surgery with AQUACEL Ag dressing post-op
  • Occupational exposure to surgical dressings

Other illness

  • Documented history of silver allergy

Who the study is looking for

  • Patients older than 18 years that underwent primary total hip arthroplasty (THA)
  • Patients older than 18 years that underwent primary total or unicompartmental knee arthroplasty (TKA/UKA)

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Rush University Medical Center
Coordinator of this site? Confirm its status
ChicagoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.